GenSight Biologics S.A. (LON:0RIM)
London
· Delayed Price · Currency is GBP · Price in EUR 0.2260
-0.0085 (-3.62%)
At close: Apr 17, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of 29.43 million as of April 24, 2025. Its market cap has increased by 9.92% in one year.
Market Cap
29.43M
Enterprise Value
43.64M
Revenue
2.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 212.26M to 29.43M, a decrease of -86.14%. That is a compound annual growth rate of -20.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.68B |
| HSBC Holdings | 148.62B |
| Shell | 146.96B |
| Unilever | 120.20B |
| Rio Tinto Group | 77.78B |
| RELX PLC | 72.64B |
| British American Tobacco p.l.c. | 69.69B |
| Rolls-Royce Holdings | 60.92B |